NCT06144736View on ClinicalTrials.gov

PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2029

Conditions
Seminoma
Interventions
PROCEDURE

Robot-assisted retroperitoneal lymph node dissection

"Robot-assisted, if possibe ipsilateral nerve-sparing, retroperitoneal lymph node dissection and metastasis resection in a unilateral dissection field (template)"

DRUG

Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin

The patient is given the option for an adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin two to four weeks after RA-RPLND

Trial Locations (1)

Unknown

RECRUITING

University Hospital of Duesseldorf, Düsseldorf

All Listed Sponsors
lead

Heinrich-Heine University, Duesseldorf

OTHER